All true FP. Well mostly true. I might have gone in a bit hard on you there earlier on as you seem to recognized the risk and have weighed that up against positives and chosen to take it on, which is fair enough. But I think you are wrong suggesting the market as a whole is similar in risk to biotechs - they are far riskier I reckon. And I'm sure what you say about analysts wanting to be right is also true. Trouble is that he probably wanted to be right in 2011 as well and that didn't work out too well. I'm jsut telling people to be careful.
bell potters no 1 biotech, page-27
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.61 |
Change
0.010(0.06%) |
Mkt cap ! $1.995B | |||
| Open | High | Low | Value | Volume |
| $15.64 | $15.93 | $15.44 | $8.412M | 538.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 558 | $15.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.66 | 1841 | 1 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |